Quick blood test for heart attack drug levels
Part of Heart & circulation clinical trials.
This trial is testing a new way to quickly measure the level of a blood thinner (tirofiban) in the blood of people having a heart attack. It aims to make sure the dose is right and safe for each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be having a specific type of heart attack called STEMI (ST-segment elevation myocardial infarction).
- Your symptoms must have started within the last 12 hours.
- You must be scheduled to get a heart procedure called PCI (angioplasty with a stent) to open the blocked artery.
- Your heart function must be fairly good (Killip class 3 or lower).
- You cannot be allergic to the study drug tirofiban or to aspirin.
- You must not have had recent bleeding problems, like a stroke or stomach bleeding, and must not be on blood thinners that you can't stop.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This study is looking at certain blood markers and heart tissue changes in people who have recently had a heart attack. The goal is to understand how the heart heals and remodels after an attack, which could help improve future treatments.
This study collects information from people who have had a heart attack to better understand the condition and improve future care. It does not test a new treatment but gathers data over time.
This trial tests if a drug called tirofiban, given directly into the heart artery, can prevent or treat no-reflow (when blood doesn't flow well even after the blockage is opened) in people having a severe heart attack known as STEMI.
This trial tests a clot-busting drug (TNK) versus a blood thinner (tirofiban) in people having a major heart attack with a large clot. If you qualify, you would get the medicine directly into your heart artery through a thin tube to see which works better.
This trial is looking at whether a blood test can help doctors choose the best treatment for people with heart disease who are getting stents. It may help make treatment more personal and effective.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.